Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Apoptosis | 15 | 2010 | 368 | 1.050 |
Why?
|
Prostatic Neoplasms | 14 | 2010 | 492 | 0.880 |
Why?
|
Membrane Glycoproteins | 10 | 2005 | 110 | 0.770 |
Why?
|
Tumor Necrosis Factor-alpha | 10 | 2005 | 213 | 0.730 |
Why?
|
Hydroxamic Acids | 3 | 2006 | 21 | 0.600 |
Why?
|
Carrier Proteins | 5 | 2006 | 141 | 0.540 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 4 | 1999 | 17 | 0.520 |
Why?
|
Apoptosis Regulatory Proteins | 10 | 2005 | 43 | 0.420 |
Why?
|
Histone Deacetylase Inhibitors | 3 | 2006 | 21 | 0.400 |
Why?
|
Caspases | 11 | 2010 | 42 | 0.370 |
Why?
|
Enzyme Inhibitors | 6 | 2007 | 176 | 0.360 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 13 | 2010 | 25 | 0.350 |
Why?
|
Mutation | 6 | 2014 | 503 | 0.340 |
Why?
|
Tumor Suppressor Protein p53 | 7 | 2014 | 79 | 0.340 |
Why?
|
beta-Thalassemia | 5 | 1994 | 11 | 0.310 |
Why?
|
Caspase 2 | 2 | 2006 | 2 | 0.300 |
Why?
|
Adenoviruses, Simian | 3 | 1996 | 3 | 0.270 |
Why?
|
Adenovirus E1A Proteins | 3 | 1996 | 10 | 0.250 |
Why?
|
Chromosomes, Human, Pair 22 | 3 | 1999 | 20 | 0.240 |
Why?
|
Chromosomes, Human, Pair 9 | 3 | 1999 | 16 | 0.240 |
Why?
|
Translocation, Genetic | 3 | 1999 | 21 | 0.240 |
Why?
|
Oncogenes | 2 | 1994 | 12 | 0.240 |
Why?
|
Cell Line, Tumor | 8 | 2014 | 736 | 0.220 |
Why?
|
Fusion Proteins, bcr-abl | 2 | 1999 | 10 | 0.210 |
Why?
|
Mitochondria | 7 | 2006 | 188 | 0.210 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 6 | 2004 | 40 | 0.200 |
Why?
|
Receptors, Androgen | 5 | 2010 | 46 | 0.200 |
Why?
|
Base Sequence | 13 | 2005 | 257 | 0.190 |
Why?
|
Pancreatic Neoplasms | 2 | 2014 | 142 | 0.190 |
Why?
|
Polymorphism, Genetic | 4 | 1995 | 194 | 0.190 |
Why?
|
Tumor Cells, Cultured | 9 | 2010 | 171 | 0.180 |
Why?
|
Molecular Sequence Data | 12 | 2002 | 359 | 0.170 |
Why?
|
Humans | 35 | 2014 | 32297 | 0.170 |
Why?
|
Codon | 3 | 1995 | 9 | 0.170 |
Why?
|
Drug Resistance, Multiple | 1 | 1999 | 9 | 0.170 |
Why?
|
Signal Transduction | 5 | 2010 | 701 | 0.160 |
Why?
|
DNA | 4 | 1997 | 229 | 0.160 |
Why?
|
Hypereosinophilic Syndrome | 1 | 1998 | 3 | 0.160 |
Why?
|
DNA, Viral | 3 | 1996 | 52 | 0.150 |
Why?
|
Receptors, Tumor Necrosis Factor | 5 | 2007 | 49 | 0.150 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2002 | 70 | 0.150 |
Why?
|
Cell Survival | 4 | 2010 | 301 | 0.140 |
Why?
|
Male | 20 | 2014 | 19488 | 0.140 |
Why?
|
Androgens | 3 | 2007 | 34 | 0.130 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1995 | 29 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-akt | 4 | 2010 | 70 | 0.130 |
Why?
|
Caspase 8 | 5 | 2007 | 14 | 0.130 |
Why?
|
Adenovirus E1B Proteins | 2 | 1996 | 19 | 0.130 |
Why?
|
Polymerase Chain Reaction | 12 | 2002 | 190 | 0.120 |
Why?
|
rab GTP-Binding Proteins | 1 | 2014 | 4 | 0.120 |
Why?
|
G1 Phase | 1 | 2014 | 11 | 0.120 |
Why?
|
Retinoblastoma Protein | 1 | 2014 | 10 | 0.120 |
Why?
|
S Phase | 1 | 2014 | 15 | 0.120 |
Why?
|
Oncogene Proteins | 1 | 2014 | 6 | 0.120 |
Why?
|
Neuroendocrine Tumors | 1 | 2014 | 21 | 0.120 |
Why?
|
Cell Proliferation | 2 | 2014 | 602 | 0.120 |
Why?
|
Genes, Viral | 1 | 1994 | 7 | 0.120 |
Why?
|
Haplotypes | 1 | 1994 | 224 | 0.120 |
Why?
|
Enzyme Activation | 4 | 2006 | 135 | 0.110 |
Why?
|
Transfection | 4 | 2010 | 202 | 0.110 |
Why?
|
Cell Transformation, Neoplastic | 1 | 1994 | 58 | 0.110 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2004 | 262 | 0.110 |
Why?
|
Caspase 9 | 4 | 2006 | 11 | 0.110 |
Why?
|
Benzylamines | 2 | 2010 | 5 | 0.110 |
Why?
|
RNA, Small Interfering | 3 | 2008 | 117 | 0.100 |
Why?
|
Sulfonamides | 2 | 2010 | 67 | 0.100 |
Why?
|
Death Domain Receptor Signaling Adaptor Proteins | 3 | 2006 | 3 | 0.100 |
Why?
|
Globins | 5 | 1993 | 8 | 0.100 |
Why?
|
Erythrocyte Membrane | 1 | 1990 | 2 | 0.090 |
Why?
|
Neuromuscular Diseases | 1 | 1990 | 14 | 0.090 |
Why?
|
Disease Models, Animal | 1 | 2014 | 1040 | 0.090 |
Why?
|
Factor IX | 3 | 1995 | 11 | 0.090 |
Why?
|
Ascorbic Acid | 1 | 2010 | 23 | 0.090 |
Why?
|
Cell Death | 2 | 2006 | 77 | 0.080 |
Why?
|
Membrane Proteins | 1 | 1990 | 260 | 0.080 |
Why?
|
Genetics, Population | 2 | 2002 | 32 | 0.080 |
Why?
|
Genes, abl | 2 | 1999 | 3 | 0.080 |
Why?
|
Animals | 8 | 2014 | 7694 | 0.080 |
Why?
|
Oxidative Stress | 1 | 2010 | 230 | 0.080 |
Why?
|
Ligands | 2 | 2005 | 89 | 0.080 |
Why?
|
Doxorubicin | 4 | 2010 | 79 | 0.070 |
Why?
|
Antibiotics, Antineoplastic | 4 | 2010 | 74 | 0.070 |
Why?
|
Neoplasms | 1 | 2014 | 695 | 0.070 |
Why?
|
DNA, Mitochondrial | 2 | 2004 | 34 | 0.070 |
Why?
|
NF-kappa B | 2 | 2004 | 82 | 0.070 |
Why?
|
Blotting, Western | 5 | 2010 | 305 | 0.070 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2007 | 6 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2007 | 264 | 0.070 |
Why?
|
Models, Biological | 2 | 2005 | 397 | 0.070 |
Why?
|
Adenocarcinoma | 1 | 2010 | 315 | 0.070 |
Why?
|
CRADD Signaling Adaptor Protein | 1 | 2006 | 1 | 0.070 |
Why?
|
Cytochromes c | 1 | 2006 | 3 | 0.070 |
Why?
|
Azerbaijan | 4 | 1994 | 4 | 0.070 |
Why?
|
MicroRNAs | 1 | 2008 | 180 | 0.070 |
Why?
|
Phosphorylation | 2 | 2003 | 234 | 0.070 |
Why?
|
Antibodies, Monoclonal | 1 | 2007 | 250 | 0.060 |
Why?
|
Tosylphenylalanyl Chloromethyl Ketone | 1 | 2004 | 1 | 0.060 |
Why?
|
Alkylating Agents | 1 | 2004 | 5 | 0.060 |
Why?
|
Mice | 3 | 2010 | 2524 | 0.060 |
Why?
|
Androstadienes | 4 | 2007 | 21 | 0.060 |
Why?
|
Polymorphism, Restriction Fragment Length | 3 | 1993 | 10 | 0.060 |
Why?
|
Luciferases | 3 | 2010 | 33 | 0.060 |
Why?
|
Fas-Associated Death Domain Protein | 4 | 2007 | 4 | 0.060 |
Why?
|
RNA, Messenger | 3 | 2006 | 534 | 0.060 |
Why?
|
Point Mutation | 2 | 1994 | 26 | 0.060 |
Why?
|
bcl-Associated Death Protein | 1 | 2003 | 7 | 0.060 |
Why?
|
Cytosol | 1 | 2003 | 27 | 0.060 |
Why?
|
Caspase 3 | 1 | 2003 | 31 | 0.060 |
Why?
|
Breast Neoplasms | 2 | 2007 | 759 | 0.060 |
Why?
|
Prenatal Diagnosis | 2 | 1993 | 27 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 3 | 2010 | 85 | 0.050 |
Why?
|
Sciuridae | 1 | 2002 | 3 | 0.050 |
Why?
|
Maleimides | 1 | 2002 | 5 | 0.050 |
Why?
|
Chimera | 1 | 2002 | 10 | 0.050 |
Why?
|
Hygromycin B | 1 | 2002 | 2 | 0.050 |
Why?
|
Cinnamates | 1 | 2002 | 5 | 0.050 |
Why?
|
Indoles | 1 | 2002 | 60 | 0.050 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2002 | 9 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2002 | 75 | 0.050 |
Why?
|
Transcription, Genetic | 1 | 2002 | 143 | 0.050 |
Why?
|
Genes, MDR | 1 | 1999 | 1 | 0.040 |
Why?
|
Immunophenotyping | 1 | 1999 | 51 | 0.040 |
Why?
|
Drug Synergism | 2 | 2010 | 71 | 0.040 |
Why?
|
Ilium | 1 | 1998 | 15 | 0.040 |
Why?
|
Autopsy | 1 | 1998 | 39 | 0.040 |
Why?
|
Fatal Outcome | 1 | 1998 | 86 | 0.040 |
Why?
|
Spleen | 1 | 1998 | 87 | 0.040 |
Why?
|
Hedgehogs | 1 | 1997 | 1 | 0.040 |
Why?
|
DNA Primers | 3 | 2005 | 90 | 0.040 |
Why?
|
Fibroblasts | 2 | 1996 | 118 | 0.040 |
Why?
|
Biopsy | 1 | 1998 | 273 | 0.040 |
Why?
|
Immunoprecipitation | 2 | 2007 | 34 | 0.040 |
Why?
|
Survival Rate | 1 | 1999 | 894 | 0.030 |
Why?
|
Sequence Deletion | 2 | 1993 | 40 | 0.030 |
Why?
|
Virus Integration | 1 | 1996 | 5 | 0.030 |
Why?
|
Chronic Disease | 1 | 1998 | 406 | 0.030 |
Why?
|
Solubility | 1 | 1995 | 38 | 0.030 |
Why?
|
Water | 1 | 1995 | 57 | 0.030 |
Why?
|
Drug Therapy, Combination | 2 | 2007 | 301 | 0.030 |
Why?
|
DNA, Satellite | 1 | 1995 | 2 | 0.030 |
Why?
|
Reference Values | 1 | 1995 | 255 | 0.030 |
Why?
|
Receptors, TNF-Related Apoptosis-Inducing Ligand | 2 | 2007 | 8 | 0.030 |
Why?
|
Female | 6 | 2014 | 20126 | 0.030 |
Why?
|
Mitosis | 1 | 2014 | 26 | 0.030 |
Why?
|
Genes, ras | 1 | 2014 | 25 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2010 | 675 | 0.030 |
Why?
|
Liver | 1 | 1998 | 486 | 0.030 |
Why?
|
Adult | 3 | 1998 | 9467 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2006 | 8 | 0.030 |
Why?
|
Hemophilia B | 1 | 1994 | 7 | 0.030 |
Why?
|
Prognosis | 1 | 1999 | 1523 | 0.030 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1994 | 19 | 0.030 |
Why?
|
Cell Line, Transformed | 1 | 1994 | 18 | 0.030 |
Why?
|
Blotting, Southern | 1 | 1994 | 24 | 0.030 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2007 | 105 | 0.030 |
Why?
|
Swine | 1 | 2014 | 216 | 0.030 |
Why?
|
Frameshift Mutation | 1 | 1993 | 6 | 0.030 |
Why?
|
Rats | 2 | 1996 | 1675 | 0.030 |
Why?
|
Base Composition | 1 | 1992 | 10 | 0.030 |
Why?
|
Restriction Mapping | 3 | 2002 | 13 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 1993 | 72 | 0.030 |
Why?
|
Gene Deletion | 1 | 1992 | 66 | 0.030 |
Why?
|
Alleles | 1 | 1993 | 252 | 0.030 |
Why?
|
Proto-Oncogene Proteins | 2 | 2002 | 94 | 0.020 |
Why?
|
Thalassemia | 1 | 1990 | 1 | 0.020 |
Why?
|
DNA Probes | 1 | 1990 | 19 | 0.020 |
Why?
|
Spectrophotometry | 1 | 1990 | 22 | 0.020 |
Why?
|
Spectrometry, Fluorescence | 1 | 1990 | 28 | 0.020 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2010 | 17 | 0.020 |
Why?
|
Russia | 2 | 2002 | 5 | 0.020 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2010 | 19 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2010 | 54 | 0.020 |
Why?
|
Cytotoxins | 1 | 2010 | 13 | 0.020 |
Why?
|
Species Specificity | 2 | 2002 | 90 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2010 | 119 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2010 | 187 | 0.020 |
Why?
|
Hydrogen Peroxide | 1 | 2010 | 83 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 920 | 0.020 |
Why?
|
Mice, Nude | 1 | 2010 | 298 | 0.020 |
Why?
|
Child | 2 | 1993 | 2472 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2014 | 1345 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2010 | 846 | 0.020 |
Why?
|
CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2007 | 2 | 0.020 |
Why?
|
Cycloheximide | 1 | 2007 | 9 | 0.020 |
Why?
|
Thapsigargin | 1 | 2007 | 9 | 0.020 |
Why?
|
Isoenzymes | 1 | 2007 | 62 | 0.020 |
Why?
|
Prostate-Specific Antigen | 1 | 2007 | 64 | 0.020 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2006 | 6 | 0.020 |
Why?
|
Leupeptins | 1 | 2006 | 6 | 0.020 |
Why?
|
Prostate | 1 | 2006 | 74 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2006 | 213 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2007 | 238 | 0.020 |
Why?
|
NF-kappa B p50 Subunit | 1 | 2004 | 5 | 0.020 |
Why?
|
Transcription Factor RelA | 1 | 2004 | 22 | 0.020 |
Why?
|
Transcription Factor AP-1 | 1 | 2004 | 19 | 0.020 |
Why?
|
RNA | 1 | 2004 | 95 | 0.010 |
Why?
|
Genetic Markers | 2 | 1993 | 125 | 0.010 |
Why?
|
Time Factors | 1 | 2008 | 2181 | 0.010 |
Why?
|
Founder Effect | 1 | 2002 | 5 | 0.010 |
Why?
|
Random Amplified Polymorphic DNA Technique | 1 | 2002 | 3 | 0.010 |
Why?
|
Pseudogenes | 1 | 2002 | 5 | 0.010 |
Why?
|
Dactinomycin | 1 | 2002 | 12 | 0.010 |
Why?
|
Protein Synthesis Inhibitors | 1 | 2002 | 11 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2002 | 31 | 0.010 |
Why?
|
Cyclins | 1 | 2002 | 6 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2002 | 8 | 0.010 |
Why?
|
Pedigree | 2 | 1994 | 141 | 0.010 |
Why?
|
Culture Media | 1 | 2002 | 45 | 0.010 |
Why?
|
Peptide Hydrolases | 1 | 2002 | 17 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2002 | 88 | 0.010 |
Why?
|
Drug Resistance | 1 | 2002 | 42 | 0.010 |
Why?
|
Precipitin Tests | 1 | 2002 | 14 | 0.010 |
Why?
|
Genes, Dominant | 1 | 2002 | 27 | 0.010 |
Why?
|
Cytochrome c Group | 1 | 2001 | 2 | 0.010 |
Why?
|
Enzyme Induction | 1 | 2001 | 33 | 0.010 |
Why?
|
Proteins | 1 | 2002 | 150 | 0.010 |
Why?
|
Pregnancy | 2 | 1993 | 1010 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2004 | 611 | 0.010 |
Why?
|
Arctic Regions | 1 | 1997 | 1 | 0.010 |
Why?
|
Cell Transformation, Viral | 1 | 1996 | 8 | 0.010 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 1995 | 7 | 0.010 |
Why?
|
Introns | 1 | 1995 | 39 | 0.010 |
Why?
|
X Chromosome | 1 | 1995 | 26 | 0.010 |
Why?
|
Cell Line | 1 | 1996 | 462 | 0.010 |
Why?
|
Deoxyribonuclease HindIII | 1 | 1993 | 1 | 0.010 |
Why?
|
Deoxyribonucleases, Type II Site-Specific | 1 | 1993 | 4 | 0.010 |
Why?
|
Hydrolysis | 1 | 1993 | 41 | 0.010 |
Why?
|
Oligonucleotide Probes | 1 | 1993 | 4 | 0.010 |
Why?
|
Recombination, Genetic | 1 | 1993 | 23 | 0.010 |
Why?
|
Tajikistan | 1 | 1992 | 1 | 0.010 |
Why?
|
DNA, Single-Stranded | 1 | 1992 | 13 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1993 | 76 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1992 | 39 | 0.010 |
Why?
|
Heterozygote | 1 | 1992 | 57 | 0.010 |
Why?
|
Fetal Diseases | 1 | 1992 | 20 | 0.010 |
Why?
|
Beta-Globulins | 1 | 1990 | 1 | 0.010 |
Why?
|
Haploidy | 1 | 1990 | 1 | 0.010 |
Why?
|